Picture of AbCellera Biologics logo

ABCL — AbCellera Biologics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Brief: Abcellera Incyte Collaborate To Accelerate Discovery And Development Of Therapeutic Antibodies In Oncology

Sept 13 (Reuters) - Abcellera Biologics Inc  ABCL.O :
    * ABCELLERA ANNOUNCES COLLABORATION WITH INCYTE TO
ACCELERATE THE
DISCOVERY AND DEVELOPMENT OF THERAPEUTIC ANTIBODIES IN ONCOLOGY
    * ABCELLERA BIOLOGICS INC: UNDER  AGREEMENT, INCYTE HAS
RIGHT TO
DEVELOP AND COMMERCIALIZE THERAPEUTIC ANTIBODIES RESULTING FROM
COLLABORATION
    * ABCELLERA BIOLOGICS: TO GET RESEARCH PAYMENTS; ELIGIBLE TO
GET
DOWNSTREAM CLINICAL, REGULATORY MILESTONE PAYMENTS, ROYALTIES ON
NET SALES OF PRODUCTS

Source text for Eikon:  ID:nBw30n1p9a 
Further company coverage:  ABCL.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on AbCellera Biologics

See all news